Hartung, Hans P: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Immune-mediated neuropathies

Kieseier, Bernd C., Mathey, Emily K., Sommer, Claudia, Hartung, Hans-Peter

Journal:

Nature Reviews Disease Primers

Year:

2018

Language:

english

File:

PDF, 2.14 MB

english, 2018

2

Monoclonal Antibodies for Multiple Sclerosis: An Update

Graf, Jonas, Aktas, Orhan, Rejdak, Konrad, Hartung, Hans-Peter

Journal:

Year:

2019

Language:

english

File:

PDF, 1.12 MB

english, 2019

3

Guillain–Barré Syndrome

Yuki, Nobuhiro, Hartung, Hans-Peter

Journal:

New England Journal of Medicine

Year:

2012

Language:

english

File:

PDF, 823 KB

english, 2012

4

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

Montalban, Xavier, Gold, Ralf, Thompson, Alan J, Otero-Romero, Susana, Amato, Maria Pia, Chandraratna, Dhia, Clanet, Michel, Comi, Giancarlo, Derfuss, Tobias, Fazekas, Franz, Hartung, Hans Peter, Havr

Journal:

Multiple Sclerosis Journal

Year:

2018

Language:

english

File:

PDF, 151 KB

english, 2018

5

Statistical aspects of on-farm experimentation

Piepho, Hans-Peter, Richter, Christel, Spilke, Joachim, Hartung, Karin, Kunick, Arndt, Thöle, Heinrich

Journal:

Crop and Pasture Science

Year:

2011

Language:

english

File:

PDF, 611 KB

english, 2011

6

Coproduction of healthcare service

Batalden, Maren, Batalden, Paul, Margolis, Peter, Seid, Michael, Armstrong, Gail, Opipari-Arrigan, Lisa, Hartung, Hans

Journal:

BMJ Quality & Safety

Year:

2016

Language:

english

File:

PDF, 597 KB

english, 2016

7

A new way to reduce the edge drop

Hartung, Hans-Georg, Hollmann, Friedrich Wilhelm, Holz, Rüdiger, Richter, Hans-Peter

Journal:

Year:

1998

Language:

english

File:

PDF, 1.32 MB

english, 1998

8

Health economics and patient outcomes of hematopoietic stem cell transplantation versus disease-modifying therapies for relapsing remitting multiple sclerosis in the United States of America

Burt, Richard K, Tappenden, Paul, Han, Xiaoqiang, Quigley, Kathleen, Arnautovic, Indira, Sharrack, Basil, Snowden, John A, Hartung, Daniel

Journal:

Multiple Sclerosis and Related Disorders

Year:

2020

File:

PDF, 1.36 MB

2020

9

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

W. Ian McDonald, Alistair Compston, Gilles Edan, Donald Goodkin, Hans-Peter Hartung, Fred D. Lublin, Henry F. McFarland, Donald W. Paty, Chris H. Polman, Stephen C. Reingold, Magnhild Sandberg-Wollhei

Journal:

Annals of Neurology

Year:

2001

Language:

english

File:

PDF, 138 KB

english, 2001

10

Drug Treatment of Clinically Isolated Syndrome

Förster, Moritz, Graf, Jonas, Mares, Jan, Aktas, Orhan, Hartung, Hans-Peter, Kremer, David

Journal:

Year:

2019

Language:

english

File:

PDF, 830 KB

english, 2019

11

Human Endogenous Retroviruses in Neurological Diseases

Küry, Patrick, Nath, Avindra, Créange, Alain, Dolei, Antonina, Marche, Patrice, Gold, Julian, Giovannoni, Gavin, Hartung, Hans-Peter, Perron, Hervé

Journal:

Trends in Molecular Medicine

Year:

2018

Language:

english

File:

PDF, 3.33 MB

english, 2018

12

The new therapeutic landscape in multiple sclerosis

Hartung, Hans-Peter, Kieseier, Bernd C.

Journal:

Current Opinion in Neurology

Year:

2014

Language:

english

File:

PDF, 138 KB

english, 2014

13

Peripheral Neuropathy: Assessment of Proximal Nerve Integrity By Diffusion Tensor Imaging

Mathys, Christian, Aissa, Joel, Zu Hörste, Gerd Meyer, Reichelt, Dorothea C., Antoch, Gerald, Turowski, Bernd, Hartung, Hans-Peter, Sheikh, Kazim A., Lehmann, Helmar C.

Journal:

Year:

2013

Language:

english

File:

PDF, 465 KB

english, 2013

14

Remyelination in multiple sclerosis

Kremer, David, Göttle, Peter, Flores-Rivera, Jose, Hartung, Hans-Peter, Küry, Patrick

Journal:

Current Opinion in Neurology

Year:

2019

File:

PDF, 375 KB

2019

15

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

Selmaj, Krzysztof, Li, David KB, Hartung, Hans-Peter, Hemmer, Bernhard, Kappos, Ludwig, Freedman, Mark S, Stüve, Olaf, Rieckmann, Peter, Montalban, Xavier, Ziemssen, Tjalf, Auberson, Lixin Zhang, Pohl

Journal:

The Lancet Neurology

Year:

2013

Language:

english

File:

PDF, 445 KB

english, 2013

16

Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis

Chun, Jerold, Hartung, Hans-Peter

Journal:

Clinical Neuropharmacology

Year:

2010

Language:

english

File:

PDF, 1001 KB

english, 2010

17

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Jeffrey A Cohen, Alasdair J Coles, Douglas L Arnold, Christian Confavreux, Edward J Fox, Hans-Peter Hartung, Eva Havrdova, Krzysztof W Selmaj, Howard L Weiner, Elizabeth Fisher, Vesna V Brinar, Gavin

Journal:

Year:

2012

Language:

english

File:

PDF, 334 KB

english, 2012

18

The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer

Hartung, Tim J., Friedrich, Michael, Johansen, Christoffer, Wittchen, Hans-Ulrich, Faller, Herman, Koch, Uwe, Brähler, Elmar, Härter, Martin, Keller, Monika, Schulz, Holger, Wegscheider, Karl, Weis, J

Journal:

Year:

2017

Language:

english

File:

PDF, 386 KB

english, 2017

19

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Chris H. Polman, Stephen C. Reingold, Gilles Edan, Massimo Filippi, Hans-Peter Hartung, Ludwig Kappos, Fred D. Lublin, Luanne M. Metz, Henry F. McFarland, Paul W. O'Connor, Magnhild Sandberg-Wollheim,

Journal:

Annals of Neurology

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

20

Bromoperoxidase activity and vanadium level of the brown alga Ascophyllum nodosum

Jens Hartung, Oliver Brücher, Diana Hach, Heiko Schulz, Hans Vilter, Gunter Ruick

Journal:

Year:

2008

Language:

english

File:

PDF, 209 KB

english, 2008

21

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

Alasdair J Coles, Cary L Twyman, Douglas L Arnold, Jeffrey A Cohen, Christian Confavreux, Edward J Fox, Hans-Peter Hartung, Eva Havrdova, Krzysztof W Selmaj, Howard L Weiner, Tamara Miller, Elizabeth

Journal:

Year:

2012

Language:

english

File:

PDF, 326 KB

english, 2012

22

PML: The Dark Side of Immunotherapy in Multiple Sclerosis

Warnke, Clemens, Olsson, Tomas, Hartung, Hans-Peter

Journal:

Trends in Pharmacological Sciences

Year:

2015

Language:

english

File:

PDF, 352 KB

english, 2015

23

The blood–nerve barrier in Wallerian degeneration: A sequential long-term study

Dr. Rüdiger J. Seitz, Karlheinz Reiners, Frank Himmelmann, Kurt Heininger, Hans-Peter Hartung, Dr. Klaus V. Toyka

Journal:

Year:

1989

Language:

english

File:

PDF, 1.01 MB

english, 1989

24

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

Ludwig Kappos, Mark S Freedman, Chris H Polman, Gilles Edan, Hans-Peter Hartung, David H Miller, Xavier Montalbán, Frederik Barkhof, Ernst-Wilhelm Radü, Carola Metzig, Lars Bauer, Vivian Lanius, Ruper

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 239 KB

english, 2009

25

Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse

Chin, Russell L., Deng, chunqin, Bril, Vera, Hartung, Hans-Peter, Merkies, Ingemar S. J., Donofrio, Peter D., Van Doorn, Pieter A., Dalakas, Marinos C., Latov, Norman

Journal:

Year:

2015

Language:

english

File:

PDF, 65 KB

english, 2015

26

Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells

Chan, Elayne M, Ratanasirintrawoot, Sutheera, Park, In-Hyun, Manos, Philip D, Loh, Yuin-Han, Huo, Hongguang, Miller, Justine D, Hartung, Odelya, Rho, Junsung, Ince, Tan A

Journal:

Nature Biotechnology

Year:

2009

Language:

english

File:

PDF, 725 KB

english, 2009

27

Chronic Inflammatory Demyelinating Polyneuropathy

Köller, Hubertus, Kieseier, Bernd C., Jander, Sebastian, Hartung, Hans-Peter

Journal:

Boston Medical and Surgical Journal

Year:

2005

Language:

english

File:

PDF, 339 KB

english, 2005

28

Macrophage-derived osteopontin induces reactive astrocyte polarization and promotes re-establishment of the blood brain barrier after ischemic stroke

Gliem, Michael, Krammes, Kristina, Liaw, Lucy, van Rooijen, Nico, Hartung, Hans-Peter, Jander, Sebastian

Journal:

Year:

2015

Language:

english

File:

PDF, 1.08 MB

english, 2015

29

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial

Comi, Giancarlo, Kappos, Ludwig, Selmaj, Krzysztof W, Bar-Or, Amit, Arnold, Douglas L, Steinman, Lawrence, Hartung, Hans-Peter, Montalban, Xavier, Kubala Havrdová, Eva, Cree, Bruce A C, Sheffield, Jam

Journal:

The Lancet Neurology

Year:

2019

Language:

english

File:

PDF, 741 KB

english, 2019

30

Failure of anti-GM1 IgG OR IgM to induce conduction block following intraneural transfer

Graham K. Harvey, Klaus V. Toyka, JÜRgen Zielasek, Reinhart Kiefer, Claudia Simonis, Hans-Peter Hartung

Journal:

Year:

1995

Language:

english

File:

PDF, 855 KB

english, 1995

31

The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system

Hans-Peter Hartung, Bernd C Kieseier

Journal:

Journal of Neuroimmunology

Year:

2000

Language:

english

File:

PDF, 873 KB

english, 2000

32

Disease-modifying therapies and infectious risks in multiple sclerosis

Winkelmann, Alexander, Loebermann, Micha, Reisinger, Emil C., Hartung, Hans-Peter, Zettl, Uwe K.

Journal:

Nature Reviews Neurology (formerly Nature Clinical Practice Neurology)

Year:

2016

Language:

english

File:

PDF, 524 KB

english, 2016

33

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

Hans-Peter Hartung, Richard Gonsette, Nikolaus Konig, Hubert Kwiecinski, Andreas Guseo, Sean P Morrissey, Hilmar Krapf, Thomas Zwingers

Journal:

Year:

2002

Language:

english

File:

PDF, 115 KB

english, 2002

34

Discovery of Molidustat (BAY 85-3934): A Small-Molecule Oral HIF-Prolyl Hydroxylase (HIF-PH) Inhibitor for the Treatment of Renal Anemia

Beck, Hartmut, Jeske, Mario, Thede, Kai, Stoll, Friederike, Flamme, Ingo, Akbaba, Metin, Ergüden, Jens-Kerim, Karig, Gunter, Keldenich, Jörg, Oehme, Felix, Militzer, Hans-Christian, Hartung, Ingo V, T

Journal:

Year:

2018

Language:

english

File:

PDF, 1.96 MB

english, 2018

35

Learning soft domain constraints in a factor graph model for template-based information extraction

ter Horst, Hendrik, Hartung, Matthias, Cimiano, Philipp, Brazda, Nicole, Müller, Hans Werner, Klinger, Roman

Journal:

Data & Knowledge Engineering

Year:

2019

Language:

english

File:

PDF, 1.16 MB

english, 2019

36

Variants of Guillain-Barré syndrome: low incidence but high impact

Helmar C. Lehmann, Hans-Peter Hartung

Journal:

Journal of Neurology

Year:

2009

Language:

english

File:

PDF, 111 KB

english, 2009

37

Sodium intake and multiple sclerosis activity and progression in BENEFIT

Fitzgerald, Kathryn C, Munger, Kassandra L, Hartung, Hans P, Freedman, Mark S, Montalbán, Xavier, Edan, Gilles, Wicklein, Eva-Maria, Radue, Ernst-Wilhelm, Kappos, Ludwig, Pohl, Christoph, Ascherio, Al

Journal:

Annals of Neurology

Year:

2017

Language:

english

File:

PDF, 1.31 MB

english, 2017

38

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Kapoor, Raju, Ho, Pei-Ran, Campbell, Nolan, Chang, Ih, Deykin, Aaron, Forrestal, Fiona, Lucas, Nisha, Yu, Bei, Arnold, Douglas L, Freedman, Mark S, Goldman, Myla D, Hartung, Hans-Peter, Havrdová, Eva

Journal:

The Lancet Neurology

Year:

2018

Language:

english

File:

PDF, 339 KB

english, 2018

39

Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies

Gerd Meyer Zu Horste, Holger Heidenreich, Helmar C. Lehmann, Soldano Ferrone, Hans-Peter Hartung, Heinz Wiendl, Bernd C. Kieseier

Journal:

Year:

2010

Language:

english

File:

PDF, 822 KB

english, 2010

40

Regulation of Fas and FasL expression on rat Schwann cells

Gisela Wohlleben, Saleh M. Ibrahim, Jens Schmidt, Klaus V. Toyka, Hans-Peter Hartung, Ralf Gold

Journal:

Year:

2000

Language:

english

File:

PDF, 492 KB

english, 2000

41

Immunopathogenesis and treatment of the guillain–barré syndrome—part II

Hans-Peter Hartung, Klaus V. Toyka, John D. Pollard, Graham K. Harvey

Journal:

Year:

1995

Language:

english

File:

PDF, 1.48 MB

english, 1995

42

The metalloproteinase-disintegrin ADAM10 is exclusively expressed by type I muscle fibers

Thomas Dehmel, Hans Hilmar Goebel, Hans-Peter Hartung, Helmar Lehmann, Heinz Wiendl, Bernd C. Kieseier

Journal:

Year:

2008

Language:

english

File:

PDF, 139 KB

english, 2008

43

The immunocompetence of Schwann cells

Gerd Meyer Zu Hörste, Wei Hu, Hans-Peter Hartung, Helmar C. Lehmann, Bernd C. Kieseier

Journal:

Year:

2008

Language:

english

File:

PDF, 184 KB

english, 2008

44

Guillain–Barré syndrome variant with prominent facial diplegia, limb paresthesia, and brisk reflexes

Helmar C. Lehmann, Stephan Macht, Sebastian Jander, Hans-Peter Hartung, Axel Methner

Journal:

Journal of Neurology

Year:

2012

Language:

english

File:

PDF, 173 KB

english, 2012

45

Plasma exchange and intravenous immunoglobulins: Mechanism of action in immune-mediated neuropathies

Helmar C. Lehmann, Hans-Peter Hartung

Journal:

Journal of Neuroimmunology

Year:

2011

Language:

english

File:

PDF, 983 KB

english, 2011

46

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

Lublin, Fred, Miller, David H, Freedman, Mark S, Cree, Bruce A C, Wolinsky, Jerry S, Weiner, Howard, Lubetzki, Catherine, Hartung, Hans-Peter, Montalban, Xavier, Uitdehaag, Bernard M J, Merschhemke, M

Journal:

Year:

2016

Language:

english

File:

PDF, 481 KB

english, 2016

47

Rig and Engine Validation of the Nonlinear Forced Response Analysis Performed by the Tool OrAgL

Hartung, Andreas, Hackenberg, Hans-Peter, Krack, Malte, Gross, Johann, Heinze, Torsten, Panning-von Scheidt, Lars

Journal:

Journal of Engineering for Gas Turbines and Power

Year:

2018

Language:

english

File:

PDF, 1.83 MB

english, 2018

48

Mycophenolate mofetil and tacrolimus: New therapeutic options in neuroimmunological diseases

Christiane Schneider-Gold, Hans-Peter Hartung, Ralf Gold

Journal:

Year:

2006

Language:

english

File:

PDF, 297 KB

english, 2006

49

Impulse Mistuning of Blades and Vanes

Hartung, Andreas, Retze, Ulrich, Hackenberg, Hans-Peter

Journal:

Journal of Engineering for Gas Turbines and Power

Year:

2017

Language:

english

File:

PDF, 1.83 MB

english, 2017

50

On the reactivity of bromoperoxidase I (Ascophyllum nodosum) in buffered organic media: Formation of carbon bromine bonds

Hartung, Jens, Dumont, Yvonne, Greb, Marco, Hach, Diana, Köhler, Franz, Schulz, Heiko, Časný, Marian, Rehder, Dieter, Vilter, Hans

Journal:

Pure & Applied Chemistry

Year:

2009

Language:

english

File:

PDF, 731 KB

english, 2009

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски